Lung Cancer Moon Shot update

submitted by: mdanderson
Lung cancer is being fought on three fronts at MD Anderson Cancer Center: prevention, early detection and treatment of advanced disease. John Heymach, M.D., Ph.D., professor in Thoracic/Head and Neck Medical Oncology at MD Anderson, talks about new developments in lung cancer research including advances in genetic mapping, molecular profiling, diagnostic imaging and lung cancer screening. With lung cancer being a part of the MD Anderson’s Moon Shots Program, we have a chance to make lung...

Improved chemotherapy administration reduces chance for medication errors

submitted by: mdanderson

MD Anderson Cancer Center is the first hospital in the United States to implement a new technology that will greatly improve chemotherapy quality control. Our main goal is patient safety. Kelley Reece, assistant manager in Pharmacy, explains how this software helps standardize the delivery of care across technicians and clinics. She also gives a behind the scenes look at how chemotherapy drugs are individually prepared for each unique patient.

Melanoma Moon Shot update 2014

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/melanoma-moon-shot-update/id43184821... . Cases of melanoma and deaths from this form of skin cancer are on the rise. MD Anderson is ideally suited to tackle this growing challenge because of our unparalleled resources and capabilities. Michael Davies, M.D., Ph.D., associate professor of Melanoma Medical Oncology at MD Anderson Cancer Center, discusses the recent advances made in the organization’s Melanoma Moon Shot program.

Chronic Lymphocytic Leukemia Moon Shot (CLL) update

submitted by: mdanderson

Chronic Lymphocytic Leukemia (CLL) is the most common adult leukemia. Michael Keating, M.D., professor in Leukemia at MD Anderson Cancer Center and one of the leaders in the CLL Moon Shot, discusses new advances in treating CLL, including alternatives to chemotherapy and using one’s own immune system to fight this disease.

Immunotherapy: unleashing immune system to attack cancer

submitted by: mdanderson
Cancer immunotherapy treats the immune system rather than the tumor. Jim Allison, Ph.D., professor in Immunology at MD Anderson Cancer Center, has developed an innovative approach that will open doors for treating all types of cancer. Padmanee Sharma, M.D., Ph.D., associate professor in Genitourinary Medical Oncology and Immunology, is lead scientist on immunotherapy clinical trials. Listen to Allison and Sharma discuss their collaboration on MD Anderson’s Moon Shots Program to develop...

Leukemia (AML/MDS) Moon Shots update

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/leukemia-aml-mds-moon-shots/id431848... . Acute Myeloid leukemia (AML) involves an overgrowth of immature blood cells, while myelodysplastic syndromes (MDS) happen when the bone marrow does not produce enough blood cells. MD Anderson Cancer Center is the world’s largest practice for treating AML and MDS. Guillermo Garcia-Manero, M.D., professor in Leukemia at MD Anderson, discusses milestones made with this MD Anderson moon shots,...

Thyroid cancer is on the rise

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/thyroid-cancer-is-on-the-rise/id4318... . The number of thyroid cancer cases is growing each year and it’s unclear why. In the United States, there were about 60,000 new thyroid cancer cases (45,310 in women, and 14,910 in men) in 2013. Thyroid cancer has a high cure rate, but it’s important to go to a specialized, multidisciplinary center to ensure proper care. Naifa Busaidy, M.D., associate professor in Endocrine Neoplasia and...

Hepatoblastoma – a rare liver cancer in children

submitted by: mdanderson

Hepatoblastoma is rare, but it’s the most primary liver tumor in children. Right now there are 100 new cases each year in the United States, but that number is gradually increasing. Susan Abraham, M.D., professor in Pathology at MD Anderson Cancer Center, discusses hereditary risks, survival, symptoms, diagnosis and treatment, including liver transplantation for hepatoblastoma patients.

Cancer screening – what you should know

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/cancer-screening-what-you/id43184821... The standard screenings for cancer are for breast, cervical, prostate and colon. For those in a high-risk category, lung, ovarian and liver cancer screenings may be recommended. Therese Bevers, M.D., medical director of Cancer Prevention at MD Anderson Cancer Center, discusses MD Anderson’s cancer screening recommendations and explains the conflicting cancer screening reports.

Proton therapy treatment for throat cancer

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/cnl-proton-throat-cancer-innovative/... Throat cancer is a general term, but it is often used to refer to cancer of the pharynx and larynx. These tumors are becoming more prevalent in young patients due to exposure to human papillomavirus (HPV) through sexual contact. Steven Frank, M.D., medical director for the Proton Therapy Center at MD Anderson Cancer Center, discusses how head and neck cancers, primarily throat cancer, can be...